Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Further evidence that TRPV1 antagonism alleviates bone cancer pain

Oct. 28, 2005

Recent Cambridge Biotechnology patent reports novel analgesic agents

Oct. 27, 2005

Recent patents disclose novel agents for the treatment of neurological disorders

Oct. 27, 2005

LY-156735 improves sleep parameters in moderate to severe insomnia

Oct. 27, 2005

Reversal of neuromuscular block achieved with ORG-25969

Oct. 27, 2005

RJR-2403 assessed in Alzheimer's disease model

Oct. 27, 2005

Adjunctive levetiracetam reduces primary tonic-clonic seizures in patients with IGE

Oct. 27, 2005

New data on the analgesic effects of gabapentin

Oct. 27, 2005

MHRA accepts for review Dyoject MAA

Oct. 27, 2005

In vivo efficacy of SL-65.0155 in Alzheimer's model

Oct. 27, 2005

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...